The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.
作者信息
Lim Wendy, Vesely Sara K, George James N
机构信息
Department of Medicine, McMaster University, Hamilton, ON, Canada; and.
Department of Biostatistics and Epidemiology, College of Public Health, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
出版信息
Blood. 2015 Mar 5;125(10):1526-31. doi: 10.1182/blood-2014-10-559211. Epub 2015 Jan 8.
Abstract
摘要
相似文献
1
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.
Blood. 2015 Mar 5;125(10):1526-31. doi: 10.1182/blood-2014-10-559211. Epub 2015 Jan 8.
2
Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
Am J Hematol. 2012 May;87 Suppl 1:S88-91. doi: 10.1002/ajh.23126. Epub 2012 Mar 9.
3
[Aphasia and thrombocytopenic thrombotic purpura in a young woman: the platelet count dilemma].
Rev Neurol. 2013 Oct 1;57(7):335-6.
4
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Blood. 2008 Jul 1;112(1):11-8. doi: 10.1182/blood-2008-02-078170.
5
[Recent therapeutic strategy for thrombotic thrombocytopenic purpura].
Rinsho Ketsueki. 2014 Jan;55(1):93-104.
6
Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
Clin Adv Hematol Oncol. 2006 Mar;4(3):215-7; discussion 217-8.
7
Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Clin Adv Hematol Oncol. 2006 Mar;4(3):210-4; discussion 217-8.
8
A case series of atypical presentations of thrombotic thrombocytopenic purpura.
J Clin Apher. 2012;27(4):221-6. doi: 10.1002/jca.21216. Epub 2012 Mar 29.
9
Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
Thromb Haemost. 2008 Jul;100(1):151-3. doi: 10.1160/TH08-02-0089.
10
[Thrombotic thrombocytopenic purpura].
Rinsho Ketsueki. 2012 Feb;53(2):185-95.
引用本文的文献
1
Thrombotic thrombocytopenic purpura in pregnancy: A case report and literature review.
Obstet Med. 2025 Jun 3:1753495X251338163. doi: 10.1177/1753495X251338163.
2
Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy.
Int J Rheum Dis. 2025 Jun;28(6):e70292. doi: 10.1111/1756-185X.70292.
3
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.
J Clin Apher. 2025 Apr;40(2):e70017. doi: 10.1002/jca.70017.
4
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.
J Clin Med. 2024 Oct 31;13(21):6561. doi: 10.3390/jcm13216561.
5
How Should Complicated Cases of Thrombotic Thrombocytopenic Purpura With Positive Coombs Test Be Treated?
Cureus. 2023 Dec 18;15(12):e50742. doi: 10.7759/cureus.50742. eCollection 2023 Dec.
6
Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience.
Int J Hematol Oncol Stem Cell Res. 2023 Jul 1;17(3):156-166. doi: 10.18502/ijhoscr.v17i3.13305.
7
Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report.
Cureus. 2023 Jul 25;15(7):e42423. doi: 10.7759/cureus.42423. eCollection 2023 Jul.
8
Clínica neurológica fluctuante: ¿Llamo al neurólogo o al hematólogo?
Adv Lab Med. 2020 Aug 17;2(1):129-136. doi: 10.1515/almed-2020-0030. eCollection 2021 Mar.
9
Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
Adv Lab Med. 2020 Nov 12;2(1):129-136. doi: 10.1515/almed-2020-0082. eCollection 2021 Mar.
10
Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura.
Blood Transfus. 2023 Sep;21(5):369-374. doi: 10.2450/BloodTransfus.503. Epub 2023 Mar 17.
本文引用的文献
1
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.
Blood. 2014 Jul 10;124(2):204-10. doi: 10.1182/blood-2014-01-550244. Epub 2014 May 28.
2
Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
J Clin Apher. 2013 Dec;28(6):390-4. doi: 10.1002/jca.21289. Epub 2013 Jul 16.
3
Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases.
Hematology. 2013 Jul;18(4):233-6. doi: 10.1179/1607845412Y.0000000073. Epub 2013 Feb 20.
4
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.
J Thromb Haemost. 2013 Mar;11(3):481-90. doi: 10.1111/jth.12114.
5
Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature.
Blood Coagul Fibrinolysis. 2012 Jun;23(4):338-41. doi: 10.1097/MBC.0b013e3283529184.
6
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.
7
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.
Blood. 2011 Aug 18;118(7):1746-53. doi: 10.1182/blood-2011-03-341131. Epub 2011 Jun 2.
8
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Transfus Apher Sci. 2010 Dec;43(3):299-303. doi: 10.1016/j.transci.2010.09.018. Epub 2010 Oct 12.
9
Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
Pediatr Hematol Oncol. 2011 Mar;28(2):167-72. doi: 10.3109/08880011003739414. Epub 2010 May 14.
10
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
Ann Hematol. 2010 Oct;89(10):1029-33. doi: 10.1007/s00277-010-0968-3. Epub 2010 Apr 27.
Zotero 插件